| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/21/2002 | WO2001083698A3 Compositions and methods for inducing activation of dendritic cells |
| 02/21/2002 | WO2001082943A3 Subcutaneous administration of coagulation factor vii |
| 02/21/2002 | WO2001082894A3 Directly compressed solid dosage particles |
| 02/21/2002 | WO2001082873A3 A medicinal aerosol formulation |
| 02/21/2002 | WO2001080837A3 Transdermal or transmucosal dosage forms with a nicotine-containing active substance combination for smoker disintoxication |
| 02/21/2002 | WO2001080619A3 Pharmaceutical composition containing citalopram |
| 02/21/2002 | WO2001076601A3 Pharmaceutical compositions comprising salmeterol and ipratropium |
| 02/21/2002 | WO2001076561A3 Pharmaceutical compositions |
| 02/21/2002 | WO2001076554A3 Drug delivery composition and device |
| 02/21/2002 | WO2001066089A3 Pharmaceutical compositions comprising cannabis |
| 02/21/2002 | WO2001058910A3 Lipid-based drug delivery systems |
| 02/21/2002 | WO2001052817A3 Cochleate formulations and their use for delivering biologically relevant molecules |
| 02/21/2002 | WO2001051008A3 Selective activation of a th1 or th2 lymphocyte regulated immune response |
| 02/21/2002 | WO2001045671A3 Suspension comprising oxcarbazepine |
| 02/21/2002 | WO2001043775A3 Hydroxide-releasing agents as skin permeation enhancers |
| 02/21/2002 | WO2001042225A3 4-pyrimidinyl-n-acyl-l-phenylalanines |
| 02/21/2002 | WO2001037812A3 Gastroretentive controlled release pharmaceutical dosage forms |
| 02/21/2002 | WO2001030323A3 Controlled-release biocompatible ocular drug delivery implant devices and methods |
| 02/21/2002 | WO2001028516A3 Sustained-release formulations for treating cns-mediated disorders |
| 02/21/2002 | WO2001026658A3 Topical nasal treatment using desloratadine |
| 02/21/2002 | WO2000069269A9 Strains of bacteriophage useful for rescuing patients infected with vancomycin-resistant enterococcus faecium |
| 02/21/2002 | US20020022826 Burst electrode |
| 02/21/2002 | US20020022816 Device |
| 02/21/2002 | US20020022798 Constant rate fluid delivery device with selectable flow rate and titratable bolus button |
| 02/21/2002 | US20020022795 Bilayer electrodes |
| 02/21/2002 | US20020022781 Products and methods for brachytherapy |
| 02/21/2002 | US20020022738 Solubility makes it possible to manufacture a solution of higher concentration of the compound and high-dosage drug product |
| 02/21/2002 | US20020022668 Use of xylitol to reduce ionic strength and activate endogenous antimicrobials for prevention and treatment of infections |
| 02/21/2002 | US20020022667 For inducing or maintaining anesthesia or sedation in a patient |
| 02/21/2002 | US20020022664 For therapy of sub-dermal plaque or scar tissue formation or accumulations, such as Peyronie's disease, Dupuytren's contracture, Ledderhose Fibrosis, scars, hemangiomas, and lipoederma ("cellulite") |
| 02/21/2002 | US20020022663 For producing analgesia in a warm blooded animal |
| 02/21/2002 | US20020022653 Cannabinoid drugs |
| 02/21/2002 | US20020022649 Stable pharmaceutical formulation |
| 02/21/2002 | US20020022629 A new class of quinolone antibiotic (e.g., moxifloxacin) is useful for treating otic, opthalmic or nasal infections attributed to a microbacterium species selected from microbacterium otitidis or microbacterium alconae |
| 02/21/2002 | US20020022618 Administering to a mammal for the inducement of sphincter continence an effective amount of an indole derivatives |
| 02/21/2002 | US20020022600 Azt derivatives exhibiting spermicidal and anti-viral activity |
| 02/21/2002 | US20020022590 Useful as antibiotics; reduced tissue accumulation and/or nephrotoxicity when administered to a mammal; useful against vancomycin-resistant microorganisms |
| 02/21/2002 | US20020022264 Delivery vehicles comprising stable lipid/nucleic acid complexes |
| 02/21/2002 | US20020022057 Pleasant taste; dissolving in mouth |
| 02/21/2002 | US20020022056 Bioavailability; core overcoated with hydrophilic permeable exterior coatings; controlling particle sizes |
| 02/21/2002 | US20020022055 After surgery, injury; supplying therapic agent to organ walls |
| 02/21/2002 | US20020022054 Drug delivery system for averting pharmacokinetic drug interaction and method thereof |
| 02/21/2002 | US20020022053 Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis, and pharmaceutical compositions and kit related thereto |
| 02/21/2002 | US20020022052 Transdermal delivery system |
| 02/21/2002 | US20020022051 For burns, injuries of skin; lyases enzyme on carrier |
| 02/21/2002 | US20020022048 Bioerosable film; adhesion to mucous membranes |
| 02/21/2002 | US20020022047 Implant device with a retinoid for improved biocompatibility |
| 02/21/2002 | US20020022042 Containing wicking fibers |
| 02/21/2002 | US20020022038 Polymeric and, or wax envelopes |
| 02/21/2002 | US20020022030 Product and process for regulation of T cell responses |
| 02/21/2002 | US20020022016 Method and system for consistent and effective encapsulation of biological material |
| 02/21/2002 | US20020022011 Vinyl acetate-vinylpyrrolidinone copolymer |
| 02/21/2002 | US20020022007 Sunscreen agents |
| 02/21/2002 | US20020020931 Sonicating aqueous solution of phospholipid to form solution of multilamellar vesicles, freezing and thawing solution, filtering to form solution of small unilamellar vesicles, curing; for renal dialysis |
| 02/21/2002 | EP1143935A3 Controlled-release biocompatible ocular drug delivery implant devices and methods |
| 02/21/2002 | DE10035865A1 Treatment or prophylaxis of migraine, by intranasal administration of aqueous spray solution of local anesthetic, preferably lidocaine hydrochloride |
| 02/21/2002 | CA2685447A1 Pharmaceutical composition |
| 02/21/2002 | CA2424160A1 Oral solid dose vaccine |
| 02/21/2002 | CA2420032A1 Oral delivery of peptide |
| 02/21/2002 | CA2419414A1 Use of triazinetrione sulfoxides for controlling coccidioses |
| 02/21/2002 | CA2419405A1 Steroid hormones as transfer agents |
| 02/21/2002 | CA2419392A1 Method for preparation of chewing gum with customer acceptable taste |
| 02/21/2002 | CA2419081A1 Micronized torsemide |
| 02/21/2002 | CA2419047A1 Water-soluble prodrugs of propofol for treatment of migraine |
| 02/21/2002 | CA2418716A1 Integrin binding motif containing peptides and methods of treating skeletal diseases |
| 02/21/2002 | CA2418490A1 Drug-containing solid dispersion having improved solubility |
| 02/21/2002 | CA2418380A1 Sutures and coatings made from therapeutic absorbable glass |
| 02/21/2002 | CA2418240A1 A disinfectant for teats of animals, and a method for improving microorganism-enviroment harmful for animals |
| 02/21/2002 | CA2417918A1 Compositions containing an inhibitor of dihydrofolate reductase and a folate |
| 02/21/2002 | CA2417813A1 Improved solid pharmaceutical dosage formulation of hydrophobic drugs |
| 02/21/2002 | CA2385591A1 Composite material and process for increasing bioavailability and activity of a beneficial agent |
| 02/20/2002 | EP1180368A1 Freeze dried hgf preparations |
| 02/20/2002 | EP1180365A2 Aerosol formulations of peptides and proteins |
| 02/20/2002 | EP1180364A1 Steroid hormones as transfer agents |
| 02/20/2002 | EP1180239A2 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer |
| 02/20/2002 | EP1180150A2 Nucleic acid immunization |
| 02/20/2002 | EP1180062A1 Method for producing morphologically uniform micro and nanoparticles using micromixers |
| 02/20/2002 | EP1180053A1 Remote and local controlled delivery of pharmaceutical compounds using electromagnetic energy |
| 02/20/2002 | EP1180049A1 Method and apparatus for treating a patient |
| 02/20/2002 | EP1180042A1 Model membrane systems |
| 02/20/2002 | EP1180033A2 Lamivudine containing pharmaceutical formulation |
| 02/20/2002 | EP1180023A2 Substrate sections with improved storage stability during their storage in bags, and a method for producing the same |
| 02/20/2002 | EP1180022A1 Process for preparing pharmaceutical bulk material having uniform dissolution |
| 02/20/2002 | EP1180021A1 Regimen and kit for amelioration of premature ejaculation |
| 02/20/2002 | EP1180020A2 Porous drug matrices and methods of manufacture thereof |
| 02/20/2002 | EP1180019A1 Antibiotic-natural polysaccharide polymer adducts |
| 02/20/2002 | EP1180018A1 Preparations for the application of anti-inflammatory agents |
| 02/20/2002 | EP1180017A1 Preparation for the application of anti-infective and/or anti-inflammatory agents |
| 02/20/2002 | EP1180016A2 Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases |
| 02/20/2002 | EP1180015A1 Generation of therapeutic microfoam |
| 02/20/2002 | EP1180014A2 Injectable anesthetic formulation |
| 02/20/2002 | EP1180013A1 Local drug delivery |
| 02/20/2002 | EP1028707B1 Sustained release ophthalmic compositions containing water soluble medicaments |
| 02/20/2002 | EP0996449B1 Pharmaceutical compositions comprising cefuroxime axetil |
| 02/20/2002 | EP0934079B1 Pharmaceutical composition containing lornoxicam and a disodic salt of edta |
| 02/20/2002 | EP0925076B1 Method to produce an implant consisting of an absorbable carrier material containing a medical active substance such as a pharmaceutical substance, an antibiotic, a cytostatic, or a hormone |
| 02/20/2002 | EP0917463B1 Tramadol multiple unit formulations |
| 02/20/2002 | EP0893994B1 Diclofenac/gamma-cyclodextrin inclusion compounds |
| 02/20/2002 | EP0885061B1 Chitin or chitin derivative microcapsules containing a hydrophobic substance, particularly a sun filter and method for preparing such microcapsules |
| 02/20/2002 | EP0843690B1 Absorbing agents for water and aqueous liquids and process for their production and use |